Principal Securities »

Ligand Pharmaceuticals In shares owned by Principal Securities

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Principal Securities from 13F filings

Historical chart of Principal Securities investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Principal Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Principal Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $53k 747 71.42

More positions owned by Principal Securities

Ishares Tr Core Us Aggbd Et (AGG)
Principal Exchange Traded Us Mega Cp Etf (USMC)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p500 Etf (IVV)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Microsoft Corporation (MSFT)
Goldman Sachs Etf Tr Access Us Agrat (GCOR)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Rus 1000 Etf (IWB)
Principal Exchange Traded Prnc Invt Grad (IG)
Amazon (AMZN)
Apple (AAPL)
Principal Exchange Traded Prncpl Vlu Etf (PY)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Principal Securities

Top funds holding Ligand Pharmaceuticals In

Vanguard Group
Henderson Group
Dimensional Fund Advisors
St. Denis J. Villere & Co
Pacer Advisors
Standard Life Aberdeen
Rice Hall James & Associates
Chicago Capital
Impax Asset Management Group
William Blair Investment Management
Deutsche Bank Aktiengesellschaft
Charles Schwab Investment Management
Bank of New York Mellon
Man Group
Kornitzer Capital Management

View all funds holding Ligand Pharmaceuticals In